ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge

By: PRLog
VSee Health, Inc. (N A S D A Q: VSEE) $VSEE Reported Q3 Revenues Reach $3.98 Million, Up 19% Year-Over-Year with Clients Including NASA, U.S. Department of Health and Human Services, McKesson, DaVita and The Nation of Qatar

NEWTON, Mass. - Dec. 16, 2025 - PRLog -- VSee Health, Inc. (N A S D A Q: VSEE), a rapidly scaling telehealth technology leader, continues to strengthen its growth trajectory following a $6.0 million private placement priced at-market, rising revenues, and a growing roster of high-profile healthcare, government, and enterprise clients. With expanding multi-year contracts, federal authorizations, and AI-powered innovation, VSee is positioning itself at the forefront of the global digital health transformation.

Strong Financial Momentum and Expanding Revenue Base

$VSEE reported Q3 2025 revenues of $3.98 million, representing 19% year-over-year growth, driven by increased adoption of its integrated telehealth platform and professional services. For the first nine months of 2025, revenues reached $10.69 million, up 60% compared to the same period in 2024, reflecting the full contribution of its iDoc acquisition and accelerating hospital partnerships.

Gross margins remained healthy at 52%, supporting scalable growth as VSee continues to execute on a pipeline of multi-year contracts expected to add millions in annual recurring revenue.

$6.0 Million Institutional Investment Strengthens Balance Sheet

On November 26, VSee announced a $6.0 million private placement with a single institutional investor, priced at an effective combined price of $0.61 per share, in line with market pricing. The capital infusion strengthens VSee's balance sheet and supports ongoing expansion initiatives across telehealth, teleradiology, and federal healthcare markets.

The financing underscores institutional confidence in VSee's long-term strategy, technology platform, and expanding revenue visibility.

AI-Powered, Modular Telehealth Platform Driving Differentiation

VSee's platform is designed as "Lego-like" digital health building blocks, allowing hospitals, governments, and enterprises to rapidly deploy customized telehealth systems without extensive development resources. Its no-code / low-code architecture, seamless EHR integrations, advanced data visualization, and enterprise-grade security provide flexibility and scalability for evolving healthcare needs.

A recent innovation, AI Doctor Notes, reduces clinical documentation time by up to 93%, directly addressing physician burnout and operational inefficiencies—key pain points across healthcare systems.

Trusted by Global Healthcare and Government Leaders

VSee's technology supports more than 1,000 clients worldwide, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, Magellan, GE, and the entire nation of Qatar. The platform handles over 1.5 million HIPAA-compliant video encounters per month and has been deployed in more than 50 countries, including underserved and remote regions.

The company also serves critical shortage areas such as critical care and teleradiology, positioning VSee as an essential infrastructure provider rather than a single-use telehealth vendor.

Major Contract Wins and iDoc Division Execution

VSee's iDoc division continues to deliver on previously announced contracts, contributing meaningfully to revenue growth:
  • Two new hospitals now live on the iDoc platform, expected to generate $500,000 in annual revenue
  • 21 of 34 hospitals activated in a major teleradiology network, with additional rollouts scheduled in early 2026
  • A $10+ million multi-year teleradiology contract with a premier Level 1 hospital system is projected to double annual recurring revenue
  • Additional proposals submitted totaling $3 million in potential contract value

These wins validate VSee's ability to deploy quickly at scale and integrate seamlessly into complex hospital systems.

Multi-Year Agreements and Scalable Revenue Models

In November, VSee secured a three-year platform services agreement with the sole Level 1 Trauma Center and leading academic health system in its metropolitan region. The volume-based, uncapped reimbursement structure enables revenue to scale directly with utilization across more than 100 hospitals and outpatient sites, with services launching January 1, 2026.

Federal Expansion and Robotics Integration

VSee recently achieved FedRAMP High Authority to Operate (ATO) from the U.S. Department of Health & Human Services, enabling deployment across federal agencies requiring the highest security standards. This authorization significantly expands VSee's addressable market.

The company is also integrating robotic telepresence solutions through its partnership with Ava Robotics, bringing remote clinician coverage into ICU settings—an innovation with the potential to transform critical care delivery.

Strategic Partnerships and Global Growth Initiatives

Beyond the U.S., VSee is pursuing expansion opportunities in Southeast Asia, engaging Philippine health leaders and former Vice President Leni Robredo to explore digital health initiatives. Strategic partnerships, including AbundaLife™, address long-standing healthcare challenges such as fragmented medical records.

Thought Leadership and Webinar with Novant Health Urgent Care

VSee recently announced a webinar with Novant Health Urgent Care, the largest urgent care provider in South Carolina, focused on building scalable, profitable virtual urgent care programs. Hosted by VSee Co-CEO Dr. Milton Chen and Novant Health's Director of Telemedicine, the event highlights VSee's role in enabling branded, efficient, and financially sustainable telehealth operations.

Positioned for a $200+ Billion Market Opportunity

With the global telehealth market projected to exceed $200 billion by 2030, VSee Health stands out as a field-tested, enterprise-grade platform with demonstrated traction, recurring revenue visibility, and expanding institutional adoption.

Backed by recent funding, growing contracts, and differentiated AI-driven technology, VSee Health continues to execute on a strategy aimed at long-term value creation in one of healthcare's fastest-growing sectors.

📈 Why VSee (N A S D A Q: VSEE) Deserves Investor Attention

VSee is more than just a telehealth platform—it's an engine of innovation powering the digital transformation of healthcare worldwide. With recurring revenue growth, major federal and global clients, AI-driven solutions, and a continued Nasdaq listing, VSEE is positioning itself for long-term, scalable success in a market expected to exceed $504 billion by 2030.

For more information on $VSEE visit: www.vseehealth.com

Media Contact:
Company Name:  VSee Health (N A S D A Q: VSEE)
Contact: Milton Chen
Email: investor@vsee.com
Phone: 626-513-1824
Country: United States
Website: www.vseehealth.com

DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website

Building the Future of Healthcare, One Digital Block at a Time.

Contact
CorporateAds
***@gmail.com

Photos: (Click photo to enlarge)

Corporate Ads Logo NASDAQ: VSEE)" target="_blank">Vsee Health (<a href=NASDAQ: VSEE)"> $VSEE Clients NASDAQ: VSEE) Team" target="_blank">$VSEE (<a href=NASDAQ: VSEE) Team"> $VSEE 10 Best Award


Source: CorporateAds

Read Full Story - VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge | More news from this source

Press release distribution by PRLog

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.35
+0.59 (0.26%)
AAPL  273.67
+1.48 (0.54%)
AMD  213.43
+12.37 (6.15%)
BAC  55.27
+1.01 (1.86%)
GOOG  308.61
+4.86 (1.60%)
META  658.77
-5.68 (-0.85%)
MSFT  485.92
+1.94 (0.40%)
NVDA  180.99
+6.85 (3.93%)
ORCL  191.97
+11.94 (6.63%)
TSLA  481.20
-2.17 (-0.45%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.